EDAP TMS S.A PE Ratio 2010-2025 | EDAP
Current and historical p/e ratio for EDAP TMS S.A (EDAP) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. EDAP TMS S.A PE ratio as of June 20, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| EDAP TMS S.A PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-20 | 1.70 | 0.00 | |
| 2025-03-31 | 1.96 | $-0.62 | 0.00 |
| 2024-12-31 | 2.21 | $-0.55 | 0.00 |
| 2024-09-30 | 2.55 | $-0.65 | 0.00 |
| 2024-06-30 | 5.44 | $-0.58 | 0.00 |
| 2024-03-31 | 7.35 | $-0.54 | 0.00 |
| 2023-12-31 | 5.28 | $-0.63 | 0.00 |
| 2023-09-30 | 7.02 | $-0.62 | 0.00 |
| 2023-06-30 | 9.22 | $-0.50 | 0.00 |
| 2023-03-31 | 11.07 | $-0.30 | 0.00 |
| 2022-12-31 | 10.66 | $-0.07 | 0.00 |
| 2022-09-30 | 8.25 | $0.11 | 75.00 |
| 2022-06-30 | 6.80 | $0.07 | 97.14 |
| 2022-03-31 | 7.25 | $-0.01 | 0.00 |
| 2021-12-31 | 5.99 | $0.01 | 0.00 |
| 2021-09-30 | 6.38 | $0.00 | 0.00 |
| 2021-06-30 | 7.09 | $0.00 | 0.00 |
| 2021-03-31 | 8.40 | $0.01 | 0.00 |
| 2020-12-31 | 5.17 | $-0.07 | 0.00 |
| 2020-09-30 | 4.60 | $-0.06 | 0.00 |
| 2020-06-30 | 2.47 | $0.01 | 247.43 |
| 2020-03-31 | 2.27 | $0.07 | 32.43 |
| 2019-12-31 | 4.43 | $0.13 | 34.08 |
| 2019-09-30 | 4.49 | $0.13 | 34.54 |
| 2019-06-30 | 2.70 | $0.07 | 38.57 |
| 2019-03-31 | 3.00 | $-0.01 | 0.00 |
| 2018-12-31 | 1.85 | $-0.02 | 0.00 |
| 2018-09-30 | 3.08 | $-0.06 | 0.00 |
| 2018-06-30 | 3.03 | $-0.05 | 0.00 |
| 2018-03-31 | 2.32 | $-0.09 | 0.00 |
| 2017-12-31 | 2.87 | $-0.03 | 0.00 |
| 2017-09-30 | 2.98 | $-0.08 | 0.00 |
| 2017-06-30 | 3.30 | $-0.01 | 0.00 |
| 2017-03-31 | 2.77 | $0.15 | 18.47 |
| 2016-12-31 | 3.28 | $0.15 | 21.87 |
| 2016-09-30 | 2.90 | $0.39 | 7.44 |
| 2016-06-30 | 3.31 | $0.12 | 27.58 |
| 2016-03-31 | 4.02 | $0.05 | 80.40 |
| 2015-12-31 | 4.13 | $-0.12 | 0.00 |
| 2015-09-30 | 5.59 | $-0.44 | 0.00 |
| 2015-06-30 | 3.25 | $0.11 | 29.55 |
| 2015-03-31 | 3.63 | $-0.23 | 0.00 |
| 2014-12-31 | 2.33 | $-0.07 | 0.00 |
| 2014-09-30 | 1.31 | $0.02 | 65.50 |
| 2014-06-30 | 4.98 | $-0.33 | 0.00 |
| 2014-03-31 | 2.86 | $-0.02 | 0.00 |
| 2013-12-31 | 2.95 | $-0.34 | 0.00 |
| 2013-09-30 | 2.53 | $-0.38 | 0.00 |
| 2013-06-30 | 2.72 | $-0.39 | 0.00 |
| 2013-03-31 | 4.17 | $-0.57 | 0.00 |
| 2012-12-31 | 2.04 | $-0.52 | 0.00 |
| 2012-09-30 | 1.71 | $-0.50 | 0.00 |
| 2012-06-30 | 1.94 | $-0.38 | 0.00 |
| 2012-03-31 | 1.90 | $-0.35 | 0.00 |
| 2011-12-31 | 1.69 | $-0.11 | 0.00 |
| 2011-09-30 | 1.75 | $-0.79 | 0.00 |
| 2011-06-30 | 3.28 | $-1.10 | 0.00 |
| 2011-03-31 | 3.49 | $-1.06 | 0.00 |
| 2010-12-31 | 5.64 | $-1.40 | 0.00 |
| 2010-09-30 | 2.41 | $-0.43 | 0.00 |
| 2010-06-30 | 2.33 | $-1.01 | 0.00 |
| 2010-03-31 | 3.16 | $-0.96 | 0.00 |
| 2009-12-31 | 2.75 | $-1.06 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.063B | $0.069B |
| EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $182.564B | 79.96 |
| Thermo Fisher Scientific (TMO) | United States | $150.197B | 18.17 |
| Edwards Lifesciences (EW) | United States | $43.309B | 28.40 |
| IDEXX Laboratories (IDXX) | United States | $42.135B | 48.42 |
| Alcon (ALC) | Switzerland | $42.123B | 28.47 |
| DexCom (DXCM) | United States | $31.369B | 48.48 |
| IQVIA Holdings (IQV) | United States | $26.768B | 14.99 |
| Mettler-Toledo (MTD) | United States | $23.982B | 28.52 |
| STERIS (STE) | Ireland | $23.183B | 25.53 |
| Waters (WAT) | United States | $20.390B | 28.77 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.638B | 0.00 |
| Hologic (HOLX) | United States | $14.369B | 15.61 |
| Sysmex ADR (SSMXY) | Japan | $10.550B | 29.93 |
| Penumbra (PEN) | United States | $9.948B | 78.08 |
| Masimo (MASI) | United States | $8.956B | 33.04 |
| Globus Medical (GMED) | United States | $7.834B | 18.67 |
| Glaukos (GKOS) | United States | $5.723B | 0.00 |
| Teleflex (TFX) | United States | $5.228B | 8.63 |
| TransMedics (TMDX) | United States | $4.179B | 90.85 |
| Integer Holdings (ITGR) | United States | $4.110B | 21.54 |
| PROCEPT BioRobotics (PRCT) | United States | $3.332B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.481B | 14.78 |
| Nihon Kohden (NHNKY) | Japan | $2.265B | 25.98 |
| Veracyte (VCYT) | United States | $2.067B | 29.00 |
| Elekta AB (EKTAY) | Sweden | $1.901B | 17.09 |
| Alphatec Holdings (ATEC) | United States | $1.599B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.292B | 121.00 |
| Pulse Biosciences (PLSE) | United States | $1.029B | 0.00 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.901B | 4.79 |
| Beta Bionics (BBNX) | United States | $0.776B | 0.00 |
| IRadimed (IRMD) | United States | $0.741B | 37.57 |
| SiBone (SIBN) | United States | $0.698B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.561B | 8.73 |
| RxSight (RXST) | United States | $0.553B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.523B | 12.25 |
| OrthoPediatrics (KIDS) | United States | $0.493B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.482B | 0.00 |
| AxoGen (AXGN) | United States | $0.443B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.407B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.405B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.403B | 10.72 |
| Pacific Biosciences Of California (PACB) | United States | $0.381B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.347B | 0.00 |
| NeuroPace (NPCE) | United States | $0.341B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| 908 Devices (MASS) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.04 |
| Neuronetics (STIM) | United States | $0.228B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.210B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.204B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.146B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.30 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.071B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.043B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.32 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |